Virginia Tech Licenses GenoCAD Source Code to ISCB
News Jan 13, 2010
Virginia Tech Intellectual Properties, an affiliated corporation of
Virginia Tech, announced at the Pacific Symposium on Biocomputing that
it has licensed the source code of GenoCAD to the International Society
for Computational Biology (ISCB).
This agreement will facilitate the open source development of GenoCAD by the synthetic biology community.
"Our initial vision for GenoCAD was to develop a web site allowing users to design synthetic genetic systems for biological research or product development programs," said Jean Peccoud, associate professor at the Virginia Bioinformatics Institute at Virginia Tech. "GenoCAD has become an open-source software development project after many users expressed a strong interest for installing GenoCAD on their own servers."
He added: "The partnership with the ISCB provides a framework allowing developers from different institutions to collaborate toward the development of a common code base without having to worry about intellectual property issues."
Virginia Tech and ISCB have jointly determined that the system of licensing agreements developed by the Apache Software Foundation provides a suitable framework to distribute software, accept regular contributions from individuals and corporations, and to accept larger grants of existing software like GenoCAD.
"Open source licensing is an integral part of our technology transfer strategy for pre-competitive software projects," said John Geikler, Senior Licensing Associate with Virginia Tech Intellectual Properties. "The partnership with ISCB allows contributors to retain full rights of use for their software while providing the scientific community, represented by ISCB, an irrevocable right to distribute and build upon an open source code."
Scott Markel, ISCB Vice President and Chair of the Publications Committee, remarked: "We are extremely pleased to enter into what we see as a first-of-kind relationship between our organization and academic institutions looking to galvanize a user and development community for open source bioinformatics software. This type of activity fits closely with the mandates of ISCB to facilitate the dissemination of computational biology tools and develop a strong computational biology community."
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE